Polycystic Ovarian Syndrome Global Clinical Trials Review, H1, 2018 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Polycystic Ovarian Syndrome Global Clinical Trials Review, H1, 2018

Description:

Polycystic Ovarian Syndrome is also known as polycystic syndrome; it is a condition which affects a woman’s hormone levels. The hormonal imbalance creates problems in the ovaries. – PowerPoint PPT presentation

Number of Views:48

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Polycystic Ovarian Syndrome Global Clinical Trials Review, H1, 2018


1
Increase In Potential Of Global Clinical Trials
For Polycystic Ovarian Syndrome Market Outlook
Ken Research
2

  • Summary
  • Global Data's clinical trial report, Polycystic
    Ovarian Syndrome Global Clinical Trials Review,
    H1, 2018 provides an overview of Polycystic
    Ovarian Syndrome clinical trials scenario. This
    report provides top line data relating to the
    clinical trials on Polycystic Ovarian Syndrome.
  • Report includes an overview of trial numbers and
    their average enrolment in top countries
    conducted across the globe. The report offers
    coverage of disease clinical trials by region,
    country (G7 E7), phase, trial status, end
    points status and sponsor type. Report also
    provides prominent drugs for in-progress trials
    (based on number of ongoing trials).
  • Global Data Clinical Trial Reports are generated
    using Global Data's proprietary database - Pharma
    eTrack Clinical trials database. Clinical trials
    are collated from 80 different clinical trial
    registries, conferences, journals, news etc
    across the globe. Clinical trials database
    undergoes periodic update by dynamic process.

3
  • POLYCYSTIC OVARIAN
    SYNDROME
  • According to the report analysis, Polycystic
    Ovarian Syndrome Global Clinical Trials Review,
    H1, 2018suggests that some of the major
    companies and health care organization are
    functioning in this market with more development
    in the clinical trials of polycystic ovarian
    syndrome which includes e. Merck kg, merck co
    inc., lo.li. Pharmasrlastellaspharmainc,
    astrazeneca plc, chemical resources genescience
    pharmaceuticals co ltd, gea a/s eugonia, bayer
    ag, novartis, glaxosmithkline, sanofi, eli lilly
    and company, johnson johnson, abbott
    laboratories, hoffmann-la roche ltd.

4
  • POLYCYSTIC
    OVARIAN SYNDROME
  • Polycystic Ovarian Syndrome is also known as
    polycystic syndrome it is a condition which
    affects a womans hormone levels. The hormonal
    imbalance creates problems in the ovaries. A
    woman who is having polycystic ovary syndrome
    produce higher-than-normal amounts of male
    hormones which genesis them to bypass menstrual
    periods and difficulty to get pregnant.
  • Irregular periods can lead to infertility and
    development of cysts in the ovaries. In some
    women, polycystic ovarian syndrome runs in the
    family whereas, the condition only occurs when
    they are overweight. Most often, women find out
    they have polycystic ovarian syndrome in their
    20s and 30s especially when they are having
    problems getting pregnant.
  • Nevertheless, polycystic ovarian syndrome can
    happen at any age after puberty. Acne on the
    face, thinning hair, skin tags, darkening of
    skin, too much hair on face, irregular menstrual
    cycle are the some major symptoms of polycystic
    ovarian syndrome.

5
  • POLYCYSTIC
    OVARIAN SYNDROME
  • Geographically, the asia-pacific, europe, north
    america, middle east and africa, central and
    south america showcase the prevalence in the
    better treatment of the polycystic ovarian
    syndrome treatment. Whereas, there is no single
    test can determine the existence of polycystic
    ovarian syndrome, blood tests to measure hormone,
    glucose levels and cholesterol and usage of
    ultrasound is done to look at the uterus and
    ovaries.
  • Additionally, for the better vaccination many key
    players and organization are benefitted with the
    mergers acquisition, joint ventures and others.
    Nevertheless, for solving the problem Polycystic
    Ovarian Syndrome many healthcare organizations
    are functioning with more improved technologies
    which resulted in the significant growth of the
    market in the near future.

6
  • Browse Full Market Report
  • Polycystic Ovarian Syndrome Global Clinical
    Trials Review, H1, 2018
  • Related Reports
  • Polycystic Ovarian Syndrome-Pipeline Review, H2
    2018
  •  
  • Polycystic Ovarian Syndrome-Pipeline Review, H2
    2016

7
About Ken Research
  • Ken Research provides bespoke industry
    intelligence, equity research reports and
    business consulting services on gamut of sectors
    across the globe. We use advanced information
    management tools, sophisticated analytical
    systems and methodologies to help our clients
    with crucial industry information for decision
    making.
  • As a leading Online Market Research Report
    Seller, Ken Research act as a platform for
    accessing statistics, forecast, business
    insights, Ideas, concepts and much more.

8
  • Contact Us
  • Ken Research
  • Ankur Gupta, Head Marketing Communications
  • sales_at_kenresearch.com
  • 91-9015378249

9
(No Transcript)
About PowerShow.com